Skip to content

Efficacy and Prognosis of Auxiliary Liver Transplantation

Efficacy and Long-term Prognosis of Auxiliary Liver Transplantation

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07275008
Enrollment
100
Registered
2025-12-10
Start date
2025-12-01
Completion date
2029-12-31
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auxiliary Liver Transplantation, Liver Transplantation

Brief summary

The objective of this observational study is to systematically compare the efficacy and patient prognosis between auxiliary liver transplantation and living donor liver transplantation, and to explore the postoperative recovery, survival rate, rejection, postoperative complications, and long-term prognosis of patients undergoing auxiliary liver transplantation.

Interventions

None listed

Sponsors

Zhi-Jun Zhu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Patients who underwent auxiliary liver transplantation or living donor liver transplantation (LDLT). 2. Patients with complete medical records and follow-up data.

Exclusion criteria

1. Patients who underwent retransplantation. 2. Patients who underwent other organ transplantation (or multiorgan transplantation). 3. Patients with severe missing postoperative follow-up data or loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Overall survivalWithin one year after liver transplantation

Secondary

MeasureTime frameDescription
ComplicationsWithin one year after liver transplantationRejection, vascular, biliary and other related complications
changes in peripheral blood lymphocyteswithin 3 months after liver transplantationPeripheral blood lymphocytes during the early post-transplant period were compared between the auxiliary and living donor liver transplantation groups to identify differences.

Contacts

Primary ContactBin Li
libin_2024@163.com+8619935943688

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026